Small bottles labeled with "Vaccine"stickers stand near a medical syringe in front of displayed "Coronavirus Covid-19"words in this illustration taken April 10, 2020 ReutersIf successful, the vaccine would be available in the second half of 2021GlaxoSmithKline Plc and Sanofi SA have announced that they would develop a vaccine to fight the fast-spreading coronavirus. The durgmakers on Tuesday said that they expect to start clinical trials for the vaccine in the second half of this year. If successful, the vaccine would be available in the second half of 2021. The announcement came at a time when durgmakers are pausing clinical trials for other disease areas as they focus on testing potential treatments for coronavirus. The adjuvanted vaccine will be developed by combining Sanofi’s S-protein Covid-19 antigen and GSK’s pandemic adjuvant technology.

Source: Dhaka Tribune April 14, 2020 17:15 UTC